Pharmaceutical compositions for binding sphingosine-1-phosphate
US9181331B2 · kind B2 · utility
0Cited by
9References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2009 |
| Grant date | Nov 10, 2015 |
| Priority date | — |
| Expiry date | Apr 9, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions that comprise an anti-S1P monoclonal antibody, antibody fragment, or derivative in a carrier, particularly a buffered, hypertonic aqueous solution, as well as to kits containing such compositions, and methods for using such compositions for treatment of diseases and conditions associated with S1P.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.